Related Experiment Video
Updated: Jul 29, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt
Insights
End-to-side portacaval shunts improved the condition of children with alpha-1-antitrypsin deficiency. This surgical procedure stabilized patients and reduced abnormal protein buildup in the liver.
Area of Science:
- Hepatology
- Pediatric Surgery
- Genetic Liver Diseases
Background:
- Alpha-1-antitrypsin deficiency is a genetic disorder that can lead to severe liver disease and portal hypertension in children.
- Portal hypertension, a complication of liver disease, presents significant clinical challenges.
Abstract:
End-to-side portacaval shunts were carried out in three children with the liver disease of alpha-1-antitrypsin deficiency and complications of portal hypertension. Their clinical courses have been stable for 3 1/2 to almost 7 years. Postoperative liver biopsy material from two of the patients showed the typical histopathological changes caused by portal diversion, as well as an apparent reduction in the quantity of alpha-1-antitrypsin particles in the hepatocytes. The metabolic changes caused by portal diversion have apparently created a more favourable equilibrium between the synthesis and excretion of the abnormal alpha-1-antitrypsin.
Related Concept Videos
Portal Hypertension
Hepatic Encephalopathy

